Patrick T. Mooney
Executive Officer, Director at Linnaeus Therapeutics.
- Haddonfield, NJ
- Linnaeus Therapeutics
Raised on Linnaeus Therapeutics filings
$6.3M
of $20M offered across 5 Form D filings
- Form D filings
- 5
- Teammates
- 8
- Last filing
- Apr 2, 2026
Company
Oral estrogen receptor agonist for melanoma
- Investors
- 25
- Still open
- $13.7M
Linnaeus Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Apr 2, 2026 | Equity | $5M/ $10M | Form D/A |
| Mar 31, 2026 | Equity | $4.9M/ $10M | Form D/A |
| Mar 13, 2026 | Equity | $4.8M/ $10M | Form D/A |
| Feb 27, 2026 | Equity | $4.5M/ $10M | Form D |
| Aug 22, 2025 | Security to be acquired | $1.3M/ $10M | Form D |
